Emerging therapies for treatment of multiple sclerosis by John R Corboy, Augusto A Miravalle

Get full text

Correspondence to: Humoral immune response to COVID-19 mRNA vaccine in patients with multiple sclerosis treated with high-efficacy disease-modifying therapies by Amanda L. Piquet, John R. Corboy, Timothy L. Vollmer

Get full text

Epstein-Barr virus is present in the brain of most cases of multiple sclerosis and may engage more than just B cells. by Asma Hassani, John R Corboy, Suhail Al-Salam, Gulfaraz Khan

Get full text

Evolution of Disease Modifying Therapy Benefits and Risks: An Argument for De-escalation as a Treatment Paradigm for Patients With Multiple Sclerosis by Brandi L. Vollmer, Andrew B. Wolf, Stefan Sillau, John R. Corboy, Enrique Alvarez

Get full text

Shifting patterns of multiple sclerosis treatment in a highly prevalent United States population by Sue Kwon, Stefan Sillau, John R. Corboy, Kavita V. Nair, Aaron M. Carlson

Get full text

Rituximab versus natalizumab, fingolimod, and dimethyl fumarate in multiple sclerosis treatment by Brandi L. Vollmer, Kavita Nair, Stefan Sillau, John R. Corboy, Timothy Vollmer, Enrique Alvarez

Get full text

Serious safety events in rituximab‐treated multiple sclerosis and related disorders by Brandi L. Vollmer, Asya I. Wallach, John R. Corboy, Karolina Dubovskaya, Enrique Alvarez, Ilya Kister

Get full text

Adjustments in Torque Steadiness During Fatiguing Contractions Are Inversely Correlated With IQ in Persons With Multiple Sclerosis by Jeffrey R. Gould, Andrew E. Reineberg, Brice T. Cleland, Kristi E. Knoblauch, Grace K. Clinton, Marie T. Banich, John R. Corboy, Roger M. Enoka

Get full text

Brain Atrophy Rates for Stable Multiple Sclerosis Patients on Long-Term Fingolimod versus Glatiramer Acetate by Justin M. Honce, Kavita V. Nair, Kavita V. Nair, Brian D. Hoyt, Brian D. Hoyt, Rebecca A. Seale, Stefan Sillau, Eric Engebretson, Brittany Schurr, John R. Corboy, Timothy L. Vollmer, Enrique Alvarez

Get full text

TMEM106B Puncta Is Increased in Multiple Sclerosis Plaques, and Reduced Protein in Mice Results in Delayed Lipid Clearance Following CNS Injury by Bridget Shafit-Zagardo, Simone Sidoli, James E. Goldman, Juwen C. DuBois, John R. Corboy, Stephen M. Strittmatter, Hillary Guzik, Ukuemi Edema, Anita G. Arackal, Yair M. Botbol, Emilio Merheb, Rashed M. Nagra, Sarah Graff

Get full text

Safety and patient experience with at‐home infusion of ocrelizumab for multiple sclerosis by Britney Barrera, Haley Simpson, Eric Engebretson, Stefan Sillau, Brooke Valdez, José Parra‐González, Ryan C. Winger, Lou Anne Epperson, Ashley Banks, Kathryn Pierce, Melanie Spotts, Katie O'Gean, Enrique Alvarez, Robert Gross, Amanda L. Piquet, Teri Schreiner, John R. Corboy, Jinglan Pei, Timothy L. Vollmer, Kavita V. Nair

Get full text